课题基金 / 基金详情

Characterization of a novel nuclear Rab protein

Characterization of a novel nuclear Rab protein
新型核 Rab 蛋白的表征
批准号:
7230197
负责人:
YING HUANG
金额:
$11.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2010-03-31

项目摘要

项目成果

YING HUANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Rab GTP-binding proteins are members of the Ras supergene family. Rab proteins are generally involved in protein transport/trafficking and determine the specificity of membrane transport steps within cell. We have identified a novel member of the Rab protein family, which we have named Nu-Rab, for its unique nuclear localization. Nu-Rab mRNA is highly expressed in most of cancer cell lines examined, and it is overexpressed in more than 60% of human primary breast cancers when compared to their matching normal tissues. The GFP- and Myc-tagged Nu-Rab mainly localizes to nucleus with some distribution noted in the cytoplasmic subcellular compartment. Immnunochemistry using Nu-Rab antibodies generated in our laboratory also detects that the endogenous Nu-Rab predominantly localizes to nucleus. Nu-Rab expression is down-regulated by apoptosis inducing agents such as ultraviolet radiation (UV), thapsigargin and sulindac sulfide. The PI3-kinase inhibitor LY294002, PI3-K phosphotase PTEN and dominant-negative mutant-Akt also down-regulate Nu-Rab mRNA expression, suggesting that Nu-Rab is a potential downstream target of the PI3-K/Akt signaling pathway. We are now proposing to further investigate the role of Nu-Rab in cell growth and/or survival and to elucidate the molecular basis of its overexpression in human breast cancer. In specific aim 1, we will analyze a larger pool of fresh-frozen and paraffin-embedded tissue specimens to evaluate the expression of Nu-Rab at the mRNA and protein levels. In specific aim 2, we will initiate functional studies to explore the effect of wild type-and GTP-binding mutants of Nu-Rab protein in oncogenic transformation. We will also explore whether Nu-Rab overexpression or deficiency effects apoptosis induced by genotoxic and non-genotoxic agents. Studies in specific aim 3 will be initiated to identify potential Nu-Rab effectors/regulator proteins in order to explore whether Nu-Rab plays a role in nuclear-cytoplasmic protein trafficking and study potential signaling events modulated by Nu-Rab. These are exploratory/developmental studies that, upon completion, will generate sufficient new data and reagents that will form the basis of future in-depth studies investigating the molecular mechanisms (s) of action of this novel GTP-binding protein in breast cancer development and/or progression.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.18632/genesandcancer.71
发表时间: 2015-07
期刊: Genes & cancer
影响因子: --
作者: [Lui K, Sheikh MS, Huang Y]
通讯作者: Huang Y
Role of a Novel Lysophospholipase in Tumorigenesis
  • 批准号:
    8209218
  • 项目类别:
  • 资助金额:
    $28.44万
  • 财政年份:
    2008
  • 负责人:
    YING HUANG
  • 依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
  • 批准号:
    7599214
  • 项目类别:
  • 资助金额:
    $29.32万
  • 财政年份:
    2008
  • 负责人:
    YING HUANG
  • 依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
  • 批准号:
    7467584
  • 项目类别:
  • 资助金额:
    $29.32万
  • 财政年份:
    2008
  • 负责人:
    YING HUANG
  • 依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
  • 批准号:
    8018083
  • 项目类别:
  • 资助金额:
    $28.44万
  • 财政年份:
    2008
  • 负责人:
    YING HUANG
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: